← Leaderboards
Lynda C Schneider
Children'S Hospital Boston
$127,516
Attributed
$127,516
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$127,516 · 8
By mechanism
M01$127,516 · 8
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Raif Salim Geha$43,046,244
- James J. Campbell$4,194,187
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHereditary Angioneurotic EdemaHuman SubjectInstitutionComplement InhibitorsFundingGrantSourceComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelResourcesUnited States National Institutes Of HealthDermatitis, AtopicImmunotherapyRecording Of Previous EventsLifeBasePatient Oriented ResearchInfectionConditionCardiovascular Disorder ChemotherapyPhenotypeImmune Response
Grant awards (13)
GENETIC AND ENVIRONMENTAL RISK FACTORS IN ATOPIC DERMATITIS$18,089
M01 · FY2007 · RR · contact PI
ADVN BIOMARKER REGISTRY STUDY$7,234
M01 · FY2007 · RR · contact PI
GENETICS OF ATOPIC DERMATITIS - ECZEMA HERPETICUM (ADEH) STUDY$5,789
M01 · FY2007 · RR · contact PI
IMMUNE RESPONSE TO VARICELLA VACCINATION IN SUBJECTS WITH ATOPIC DERMATITIS$2,170
M01 · FY2007 · RR · contact PI
EDEMA2:EVALUATION OF DX-88'S EFFECTS IN MITIGATING ANGIOEDEMA, AN OPEN LABEL STD$37,662
M01 · FY2006 · RR · contact PI
EDEMA2:EVALUATION OF DX-88'S EFFECTS IN MITIGATING ANGIOEDEMA, AN OPEN LABEL STD$38,493
M01 · FY2005 · RR
DX-88 IN HEREDITARY ANGIOEDEMA$6,536
M01 · FY2005 · RR
DX-88 in Hereditary Angioedema$8,564
M01 · FY2004 · RR
EDEMA2:Evaluation of DX-88's Effects In Mitigating Angioedema, An Open Label Std$2,979
M01 · FY2004 · RR
VAPOR HEATED C-1 INHIBITOR IMMUNOTHERAPY IN HAE$0
M01 · FY2002 · RR
VAPOR HEATED C-1 INHIBITOR IMMUNOTHERAPY IN HAE$0
M01 · FY2001 · RR
VAPOR HEATED C-1 INHIBITOR IMMUNOTHERAPY IN HAE$0
M01 · FY2001 · RR
VAPOR HEATED C-1 INHIBITOR IMMUNOTHERAPY IN HAE$0
M01 · FY2000 · RR